Philippe Deschamps - 11 Feb 2026 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Philippe Deschamps
Issuer symbol
COEP
Transactions as of
11 Feb 2026
Net transactions value
+$60,192
Form type
4
Filing time
13 Feb 2026, 17:00:12 UTC
Previous filing
10 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Deschamps Philippe Director 105 BRADFORD ROAD, SUITE 420, WEXFORD /s/ Philippe Deschamps 13 Feb 2026 0001638231

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common stock Options Exercise $60,192 +5,700 +175% $10.56 8,950 11 Feb 2026 Direct F1
transaction COEP Common Stock Award $0 +3,250 +57% $0.000000 8,950 11 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise price of shares purchased upon exercise of stock options.
F2 Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.